Today: 16 April 2026
CXApp (CXAI) stock jumps after workplace analytics flags desk “no-shows” at big enterprise client
5 March 2026
2 mins read

CXApp (CXAI) stock jumps after workplace analytics flags desk “no-shows” at big enterprise client

NEW YORK, March 5, 2026, 06:14 EST

  • CXApp reported that at one major enterprise tech client, a significant portion of reserved desks ended up sitting empty, according to its workplace analytics.
  • The stock jumped roughly 10% ahead of the U.S. open.
  • Just days out from a Nasdaq deadline over the stock’s sub-$1 bid price, the update lands.

CXApp Inc shares jumped roughly 10% ahead of Thursday’s U.S. session, with the move coming as the company pointed to workplace analytics results tied to a significant enterprise tech customer. At $0.20, the stock puts the software provider’s market cap near $17 million.

The update arrives while employers grapple with hybrid schedules. Office space isn’t cheap, and misjudging needs can stick companies with vacant floors. No wonder interest is up in tools for tracking desk reservations and how space actually gets used.

CXApp, which is listed on Nasdaq as CXAI and CXAIW for its shares and warrants, faces pressure from a ticking listing deadline. According to a regulatory filing, Nasdaq has given the company until March 10, 2026 to bring its share price back above the $1 mark for a minimum of 10 consecutive trading sessions. If CXApp can’t clear that bar, it could get an extra 180 days to comply before delisting becomes a real risk.

CXApp’s CXAI VU Analytics platform tracked over 100,000 desk bookings across a multi-site corporate workforce, the company said, with users logging more than 35,000 app sessions and around 1,800 kiosk sessions. Roughly 19% of those bookings were auto-released due to no-shows, and another 15% ended up canceled. Actual desk occupancy came in at an average of 66%, according to the data, though some departments were seeing no-show rates above 75% late in the week. CEO Khurram Sheikh described the trend as “measurable economic leakage” from space that gets booked but never used. ACCESS Newswire

CXApp claims its platform applies behavioral modeling and anomaly detection tech to flag bookings that might be at risk. Executives also get access to “natural language” analytics, so they can type out questions in plain English, plus a “transparent” analytics layer that lays out exactly how the results come together. The Palo Alto, California-based company is calling this expanded offering “agentic AI,” pitching the software as more than a Q&A tool—CXApp says it’s designed to actually launch actions and workflows based on data signals. cxapp.com

The company is working on predictive tools—think forecasting, plus signals to flag potential no-shows. It’s pitching this as a move away from just reporting what happened, toward interventions: tightening policies or shifting capacity before problems crop up.

Competition is stiff in workplace booking and utilization software, as major players load these features into bigger enterprise packages. ServiceNow targets workplace services and reservations through its workplace service delivery tools, and Microsoft’s Places brings in desk booking along with occupancy and space utilization metrics.

Even so, translating utilization stats into real savings isn’t always straightforward. These systems rely on employees actually showing up, while managers need both the power and the will to shut down floors or rethink routines when the data turns sour.

CXApp hasn’t disclosed the enterprise client or specified how much could be saved, so investors are left to guess the revenue implications. The board already has the green light from shareholders for a reverse stock split—anywhere from 1-for-5 to 1-for-10, according to a separate filing—in an effort to keep the company’s shares trading on the Nasdaq.

Stock Market Today

  • ASX Penny Stocks to Watch April 2026: Frontier Energy and Imricor Medical Systems
    April 15, 2026, 10:34 PM EDT. As the ASX approaches 9,000 points, penny stocks offer potential growth amid mixed market signals. Frontier Energy Limited (ASX:FHE), valued at A$146.27 million, targets renewable energy with a promising Waroona Project expected to yield A$32 million annually from 2027. The company is debt-free and recently appointed Jamie Cullen as Executive Chairman. Imricor Medical Systems (ASX:IMR), a medical device firm with a A$632.27 million market cap, posted US$0.29 million revenue in 2025. Despite a -219.72% return on equity, it holds more cash than debt and expects 89% revenue growth and a 32% stock price rise. Both stocks remain pre-revenue but show strong leadership and financial stability amid local and global market challenges.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
BW stock jumps after Babcock & Wilcox gets $2.4 billion green light to build AI data-center power project
Previous Story

BW stock jumps after Babcock & Wilcox gets $2.4 billion green light to build AI data-center power project

Hong Kong’s 2,000-Tonne Gold Vault Plan Gets Fresh Incentives as China Eyes Bullion Pricing Power
Next Story

Hong Kong’s 2,000-Tonne Gold Vault Plan Gets Fresh Incentives as China Eyes Bullion Pricing Power

Go toTop